Finance

Beta
Lists
CHE:NYSE
Chemed Corp
$446.26
+1.62%
(+7.13) 1D
$446.26
0.00% (0.00)
After hours
Closed: Jun 9, 4:00:07 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CHE...
Open
$440.77
High
$449.21
Low
$440.25
Mkt. cap
5.92B
Avg. vol.
230.28K
Volume
3.00
Dividend
0.54%
Quarterly dividend
$0.60
Ex-dividend date
May 28, 2026
P/E ratio
24.31
52-wk high
$562.76
52-wk low
$365.20
EPS
$18.36
Beta
0.54
Shares outstanding
13.27M
No. of employees
16K
Open
$440.77
High
$449.21
Low
$440.25
Mkt. cap
5.92B
Avg. vol.
230.28K
Volume
3.00
Dividend
0.54%
Quarterly dividend
$0.60
Ex-dividend date
May 28, 2026
P/E ratio
24.31
52-wk high
$562.76
52-wk low
$365.20
EPS
$18.36
Beta
0.54
Shares outstanding
13.27M
No. of employees
16K
Analyst outlook
Analyst Ratings
Based on 2 analysts giving stock ratings to CHE in the past 3 months
Buy
Buy
1
Hold
1
Sell
0
12 month forecast
Based on 2 Wall Street analysts offering 12 month price targets for CHE in the last 3 months.
Highest
Current $446.26
$500.00 (+12.04%)
Average
$468.00 (+4.87%)
Lowest
$436.00 (-2.30%)
News stories
From sources across the web
About Chemed Corp
CEOKevin J Mcnamara
Employees15.8K
Founded1970
HeadquartersCincinnati, Ohio, United States
SectorHealth care provider
Websitechemed.com
Last report
Apr 24, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
$5.65 / $5.30
+6.55%beat
Revenue / Est. (USD)
657.51M / 649.82M
+1.18%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
618.80M
624.90M
639.34M
657.51M
Cost of goods sold
434.10M
427.99M
414.17M
441.75M
Cost of revenue
434.10M
427.99M
414.17M
441.75M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
100.32M
105.78M
102.80M
114.32M
Operating expense
116.61M
122.16M
118.91M
131.19M
Total operating expenses
550.71M
550.15M
533.07M
572.94M
Operating income
68.08M
74.75M
106.26M
84.58M
Other non operating income
919.00K
6.70M
3.75M
3.88M
EBT including unusual items
71.12M
83.54M
105.44M
88.84M
EBT excluding unusual items
71.12M
83.54M
111.05M
88.84M
Income tax expense
18.62M
19.31M
28.69M
22.54M
Effective tax rate
26.19%
23.11%
27.21%
25.37%
Other operating expenses
26.00K
148.00K
-225.00K
-8.00K
Net income
52.49M
64.24M
76.75M
66.30M
Net profit margin
8.48%
10.28%
12.00%
10.08%
Earnings per share
4.27
5.27
6.42
5.65
Interest and investment income
2.56M
2.56M
1.56M
890.00K
Interest expense
-443.00K
-457.00K
-521.00K
-512.00K
Net interest expenses
2.11M
2.10M
1.04M
378.00K
Depreciation and amortization charges
13.69M
13.66M
13.76M
14.30M
EBITDA
84.34M
90.98M
118.29M
101.45M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more